Towa Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Towa Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Kaken Pharmaceutical Co Ltd
sales of 98.43 billion Japanese Yen [US$868.15 million]
of which 98%
Nippon Shinyaku Co Ltd
(101.45 billion Japanese Yen [US$894.77 million]
of which 86%
was Pharmaceutical Products), and
Mochida Pharmaceutical Company Limited
(106.76 billion Japanese Yen [US$941.63 million]
of which 100%
was Pharmaceutical Business).
Towa Pharmaceutical Company Limited reported sales of ¥93.43 billion (US$824.05 million)
March of 2018.
increase of 10.0%
versus 2017, when the company's sales were ¥84.95 billion.
Sales at Towa Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 69%).